NK cell influence on the outcome of primary Epstein Barr virus infection
The herpesvirus Epstein Barr virus (EBV) was discovered as the first human candidate tumor virus in Burkitt’s lymphoma more than 50 years ago. Despite its strong growth transforming capacity, more than 90% of the human adult population carries this virus asymptomatically under near perfect immune co...
Main Authors: | Obinna Chijioke, Vanessa Landtwing, Christian Münz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00323/full |
Similar Items
-
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
by: Henry H. Balfour, et al.
Published: (2022-08-01) -
Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
by: Christian Münz
Published: (2017-11-01) -
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR− NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
by: Janice K. P. Lam, et al.
Published: (2020-06-01) -
Epstein-Barr virus: the molecular virology and the associated diseases
by: Takayuki Murata
Published: (2023-05-01) -
Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
by: Vincent Jean-Pierre, et al.
Published: (2021-06-01)